Table 1

Characteristics of study population

Clinical dataPCDSinusitisControlsTukey’s test
P
PCD
/sinusitis
P
PCD
/controls
P
sinusitis/
controls
Subjects, n62*2543 – – –
 Men n (%)†31 (50)14 (56)19 (44) – – –
 Children n (%)23 (37)10 (40)16 (37) – – –
Age, years, median (L-UQ)21.4 (15.9 to 36.1)21.5 (14.9 to 40.2)26.3 (11.9 to 28.6)0.8790.3590.276
Nasal nitric oxide, nL/min median (L-UQ)31.8 (16.3 to 49.8)77.6 (72.0 to 82.2)200.7 (197.9 to 201.7)<0.0001<0.0001<0.0001
Olfactory assessment (mean)
 Threshold (95% CI)3.6 (3.0 to 4.2)4.6 (4.2 to 4.9)6.2 (5.9 to 6.5)0.040<0.0001<0.001
 Discrimination (95% CI)8.4 (7.2 to 9.4)11.5 (10.8 to  11.9)12.3 (11.8 to 12.8)0.001<0.00010.479
 Blue identification (95%  CI)9.3 (8.2 to  10.2)11.6 (11.1 to  12.2)12.5 (11.7 to 13.2)0.007<0.00010.513
 Purple identification (95%  CI)8.6 (7.6 to 9.6)11.7 (11.1 to  12.1)12.6 (12.0 to 13.2)0.0002<0.00010.447
 TDI score (95%  CI)21.2 (18.7 to  23.6)27.6 (26.6 to  28.6)31.1 (29.9 to 32.2)0.001<0.00010.142
 TDI extended score (95%  CI)29.8 (26.4 to  33.2)39.3 (37.9 to  40.6)43.7 (42.1 to 45.3)0.0003<0.00010.187
CT scanning of paranasal sinuses
 Modified Lund-Mackay score, median (L-UQ)12.0 (9.8 to 17.7)11.0 (9.0 to 14.0)NA0.100 – –
 Sinus aplasia or hypoplasia score, median (L-UQ)3.0 (0.0 to 4.0)3.0 (1.25 to 4.0)NA0.920 – –
  • *CT scanning of paranasal sinuses in 57 patients with PCD.

  • †Men vs women: P=0.634 (χ2 test).

  • L-UQ, lower–upper quartile; NA, not applicable; PCD, primary ciliary dyskinesia; TDI,Threshold Discrimination Identification.